Abstract
Reduced inositol monophosphatase (IMPase) activity and elevated basal intracellular calcium levels ([Ca2+]B) have been reported in B lymphoblast cell lines (BLCLs) from bipolar I affective disorder (BD-I) patients, which may reflect cellular endophenotypes of this disorder. As the PI cycle couples to intracellular Ca2+ mobilization, these two putative endophenotypes may be related. Using an RT-PCR assay, mRNA levels were estimated for IMPA1 and 2 genes encoding human IMPase 1 and 2, respectively, in BLCLs phenotyped on [Ca2+]B, from patients with a DSM-IV diagnosis of BD-I (n = 12 per phenotype) and from age- and sex-matched healthy subjects (n = 12). IMPA2 mRNA levels were significantly lower in BLCLs from male BD-I patients with high [Ca2+]B (n = 6) compared with healthy male subjects (n = 5) (−52%, P = 0.013), male BD-I patients with normal BLCL [Ca2+]B (n = 8) (−42%, P = 0.003) and female BD-I patients with high [Ca2+]B (n = 6) (−59%, P = 0.0004). A significant negative correlation was observed between IMPA2 mRNA levels and [Ca2+]B in BLCLs from male (P = 0.046), but not female BD-I patients. Sex-dependent differences were also evident in postmortem temporal cortex IMPA2 mRNA levels which, in contrast to BLCLs, were significantly higher in male BD-I subjects compared with male controls (P = 0.025, n = 4/group). Collectively, these observations suggest a potential sex-dependent link between abnormalities in IMPA2 expression and calcium homeostasis in the pathophysiology of BD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Craddock N, Jones I . Genetics of bipolar disorder J Med Genet 1999 36: 585–594
Gershon ES, Badner JA, Goldin LR, Sanders AR, Cravchik A, Detera-Wadleigh SD . Closing in on genes for manic-depressive illness and schizophrenia Neuropsychopharmacology 1998 18: 233–242
Leboyer M, Bellivier F, Nosten-Bertrand M, Jouvent R, Pauls D, Mallet J . Psychiatric genetics: search for phenotypes Trends Neurosci 1998 21: 102–105
Emamghoreishi M, Schlichter L, Li PP, Parikh S, Sen J, Kamble A et al. High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder Am J Psychiatry 1997 154: 976–982
Atack JR . Inositol monophosphatase, the putative therapeutic target for lithium Brain Res Brain Res Rev 1996 22: 183–190
Shamir A, Ebstein RP, Nemanov L, Zohar A, Belmaker RH, Agam G . Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy Mol Psychiatry 1998 3: 481–482
Nemanov L, Ebstein RP, Belmaker RH, Osher Y . Effect of bipolar disorder on lymphocyte inositol monophosphatase mRNA levels Int J Neuropsychopharmacol 1999 2: 25–29
Berridge MJ, Irvine RF . Inositol trisphosphate, a novel second messenger in cellular signal transduction Nature 1984 312: 315–321
Fisher SK, Heacock AM, Agranoff BW . Inositol lipids and signal transduction in the nervous system: an update J Neurochem 1992 58: 18–38
Sjoholt G, Molven A, Lovlie R, Wilcox A, Sikela JM, Steen VM . Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA) Genomics 1997 45: 113–122
Yoshikawa T, Turner G, Esterling LE, Sanders AR, Detera-Wadleigh SD . A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder Mol Psychiatry 1997 2: 393–397
Berrettini WH . Genetics of psychiatric disease Annu Rev Med 2000 51: 465–479
Parthasarathy L, Vadnal RE, Parthasarathy R, Devi CSS . Biochemical and molecular properties of lithium-sensitive myo-inositol monophosphatase Life Sci 1994 54: 1127–1142
Rahman S, Li PP, Young LT, Kofman O, Kish SJ, Warsh JJ . Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder J Neurochem 1997 68: 297–304
Vogt T, Stolz W, Welsh J, Jung B, Kerbel RS, Kobayashi H et al. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas Clin Cancer Res 1998 4: 791–797
Winer BJ . Statistical Principles in Experimental Design, 2nd edn McGraw-Hill Book Co: New York 1971 pp 456–457
Soares JC, Mann JJ . The functional neuroanatomy of mood disorders J Psychiatr Res 1997 31: 393–432
Li PP, Andreopoulos S, Warsh JJ . Signal transduction abnormalities in bipolar affective disorder. In: Reith MEA (ed) Cerebral Signal Transduction: From First to Fourth Messengers Humana Press: Totowa, New Jersey 2000 pp 283–309
Samuelson SD, Winokur G, Pitts AF . Elevated cerebrospinal fluid protein in men with unipolar or bipolar depression Biol Psychiatry 1994 35: 539–544
Emamghoreishi M, Li PP, Schlichter L, Parikh SV, Cooke R, Warsh JJ . Associated disturbances in calcium homeostasis and G protein-mediated cAMP signaling in bipolar I disorder Biol Psychiatry 2000 48: 665–673
Yoshikawa T, Padigaru M, Karkera JD, Sharma M, Berrettini WH, Esterling LE et al. Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2) Mol Psychiatry 2000 5: 165–171
Shimon H, Agam G, Belmaker RH, Hyde TM, Kleinman JE . Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder Am J Psychiatry 1997 154: 1148–1150
Slusarski DC, Corces VG, Moon RT . Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling Nature 1997 390: 410–413
Acknowledgements
This work was supported by grants from the Medical Research Council of Canada (JJW) and the National Alliance for Research on Schizophrenia and Affective Disorders (JJW and PPL). The authors thank Mrs Cathy Spegg for advice in performing the statistical analyses.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoon, IS., Li, P., Siu, KP. et al. Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder. Mol Psychiatry 6, 678–683 (2001). https://doi.org/10.1038/sj.mp.4000901
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000901
Keywords
This article is cited by
-
A novel function of IMPA2, plays a tumor-promoting role in cervical cancer
Cell Death & Disease (2020)
-
Lack of Lithium-Like Behavioral and Molecular Effects in IMPA2 Knockout Mice
Neuropsychopharmacology (2007)
-
A Promoter Haplotype of the Inositol Monophosphatase 2 Gene (IMPA2) at 18p11.2 Confers a Possible Risk for Bipolar Disorder by Enhancing Transcription
Neuropsychopharmacology (2007)
-
Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders
Molecular Psychiatry (2004)
-
Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder
Molecular Psychiatry (2004)